Works matching IS 15747891 AND DT 2022 AND VI 16 AND IP 11

Results: 9

A novel AMPK activator shows therapeutic potential in hepatocellular carcinoma by suppressing HIF1α-mediated aerobic glycolysis.

Published in:

Molecular Oncology, 2022, v. 16, n. 11, p. 2274, doi. 10.1002/1878-0261.13211

By:

Tseng, Hsing-I.;
Yi-Siang Zeng;
Ying-Chung Jimmy Lin;
Jui-Wen Huang;
Chih-Lung Lin;
Meng-Hsuan Lee;
Fan-Wei Yang;
Te-Ping Fang;
Ai-Chung Mar;
Jung-Chen Su

Publication type:

Article

Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study.

Published in:

Molecular Oncology, 2022, v. 16, n. 11, p. 2260, doi. 10.1002/1878-0261.13173

By:

Jary, Marine;
Wen-Wei Liu;
Dongyao Yan;
Bai, Isaac;
Muranyi, Andrea;
Colle, Elise;
Brocheriou, Isabelle;
Turpin, Anthony;
Radosevic-Robin, Nina;
Bourgoin, Pierre;
Penault-Llorca, Frédérique;
Cohen, Romain;
Vernerey, Dewi;
André, Thierry;
Borg, Christophe;
Shanmugam, Kandavel;
Svrcek, Magali

Publication type:

Article

AR/D1A-deficient cells require HDAC6 for progression of endometrial carcinoma.

Published in:

Molecular Oncology, 2022, v. 16, n. 11, p. 2235, doi. 10.1002/1878-0261.13193

By:

Megino-Luque, Cristina;
Sisó, Pol;
Mota-Martorell, Natalia;
Navaridas, Raúl;
de la Rosa, Inés;
Urdanibia, Izaskun;
Albertí-Valls, Manel;
Santacana, Maria;
Pinyol, Miquel;
Bonifaci, Núria;
Macià, Anna;
Llobet-Navas, David;
Gatius, Sònia;
Matias-Guiu, Xavier;
Eritja, Núria

Publication type:

Article

Anti-Chi3L1 antibody suppresses lung tumor growth and metastasis through inhibition of M2 polarization.

Published in:

Molecular Oncology, 2022, v. 16, n. 11, p. 2214, doi. 10.1002/1878-0261.13152

By:

Ji Eun Yu;
In Jun Yeo;
Dong Ju Son;
Jaesuk Yun;
Sang-Bae Han;
Jin Tae Hong

Publication type:

Article

Integrative analysis of immune-related multi-omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma.

Published in:

Molecular Oncology, 2022, v. 16, n. 11, p. 2174, doi. 10.1002/1878-0261.13160

By:

Deyao Shi;
Shidai Mu;
Feifei Pu;
Jianxiang Liu;
Binlong Zhong;
Binwu Hu;
Na Ni;
Hao Wang;
Luu, Hue H.;
Haydon, Rex C.;
Le Shen;
Zhicai Zhang;
Tong-Chuan He;
Zengwu Shao

Publication type:

Article

Pan-cancer analysis reveals sex-specific signatures in the tumor microenvironment.

Published in:

Molecular Oncology, 2022, v. 16, n. 11, p. 2153, doi. 10.1002/1878-0261.13203

By:

Junwei Han;
Yang Yang;
Xiangmei Li;
Jiashuo Wu;
Yuqi Sheng;
Jiayue Qiu;
Qian Wang;
Ji Li;
Yalan He;
Liang Cheng;
Yan Zhang

Publication type:

Article

Precision N-glycoproteomics reveals elevated LacdiNAc as a novel signature of intrahepatic cholangiocarcinoma.

Published in:

Molecular Oncology, 2022, v. 16, n. 11, p. 2135, doi. 10.1002/1878-0261.13147

By:

Jun Li;
Ting Zhao;
Jing Li;
Jiechen Shen;
Li Jia;
Bojing Zhu;
Liuyi Dang;
Chen Ma;
Didi Liu;
Fan Mu;
Liangshuo Hu;
Shisheng Sun

Publication type:

Article

Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment.

Published in:

Molecular Oncology, 2022, v. 16, n. 11, p. 2117, doi. 10.1002/1878-0261.13146

By:

Gulley, James L.;
Schlom, Jeffrey;
Barcellos-Hoff, Mary Helen;
Xiao-Jing Wang;
Seoane, Joan;
Audhuy, Francois;
Yan Lan;
Dussault, Isabelle;
Moustakas, Aristidis

Publication type:

Article

Integrating bulk and single-cell RNA sequencing reveals cellular heterogeneity and immune infiltration in hepatocellular carcinoma.

Published in:

Molecular Oncology, 2022, v. 16, n. 11, p. 2195, doi. 10.1002/1878-0261.13190

By:

Tingjie Wang;
Ningxin Dang;
Guangbo Tang;
Zihang Li;
Xiujuan Li;
Bingyin Shi;
Zhong Xu;
Lei Li;
Xiaofei Yang;
Chuanrui Xu;
Kai Ye

Publication type:

Article